Month: January 2023

The obesity crusader using tech to tackle ill health  The Timessource

Ry­bel­sus, No­vo Nordisk’s GLP-1 al­so known as semaglu­tide, snagged a la­bel up­date from the FDA, al­low­ing pa­tients to take it as a first-line treat­ment for Type II di­a­betes in 7…

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) announced top-line results from its Phase 3 trial (ORA-D-013-1) comparing the efficacy of ORMD-0801 to placebo in patients with Type 2 Diabetes (T2D) at 26 weeks.ORA-D-013-1…

e-EditionSign up for email newsletters Sign up for email newsletterse-EditionSo it’s been a while since I’ve written about my weight.Not because I was skipping out on the “accountability,” that I’ve…

Click here to sign in with or Forget Password? Learn more share this!4318ShareEmail January 13, 2023 by Adrianna MacPherson, University of Alberta Researchers have found that a class of older…

Every Friday, Perfect Daily Grind rounds up the top coffee industry news from the previous week. Here are this week’s stories.Here are a few news stories from previous weeks that…

One of the common medical problems senior citizens suffer from is Type 2 diabetes mellitus (maturity onset diabetes). Roughly one third of the population after the age of 65 years…

If you have diabetes, your doctor might suggest Admelog as a treatment option. It’s a prescription drug used to treat:The active ingredient in Admelog is insulin lispro. (The active ingredient…

Published: 6:15pm, 15 Jan, 2023Updated: 6:15pm, 15 Jan, 2023 source

Intermittent fasting is an increasingly popular weight loss dieting strategy. Beyond weight loss however, the diet has promising benefits that may reduce the risk of developing some chronic, lifestyle diseases.…